Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | C1 esterase inhibitor | - | - | - | - | [1] 65 65 💬
|
| 2 | C1 esterase inhibitor [human] liquid | - | - | - | - | [1] 65 65 💬
|
| 3 | C1 esterase inhibitor concentrate | - | - | - | - | [1] 65 65 💬
|
| 4 | C1 esterase inhibitor concentrate, human, pasteurized | - | - | - | - | [1] 65 65 💬
|
| 5 | C1 esterase inhibitor human | - | - | - | - | [1] 65 65 💬
|
| 6 | C1 esterase inhibitor liquid FOR injection | - | - | - | - | [1] 65 65 💬
|
| 7 | Complement C1 esterase inhibitor | [1] Conestat alfa Conestat alfa (Recombinant complement C1 esterase inhibitor) | [1] Conestat alfa
Conestat alfa
💬
| [3] C1R C1R,C1S, KLKB1 💬 | [6] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [2] 61 61, 65 💬
|
| 8 | Recombinant human C1 esterase inhibitor | - | - | - | - | [1] 65 65 💬
|
